bio sketch column
Rishi K. Jain is currently a group leader in the Global Discovery Chemistry organization of Novartis (NIBR). His group focuses on the establishment of innovative research programs spanning various therapeutic areas through the integration of medicinal chemistry, phenotypic screening and molecular target identification techniques. He is also responsible for co-leading the development of Novartis’ chemical probe collection. Prior to Novartis, he trained with Prof. Jonathan A. Ellman at U.C. Berkeley (2002-2004) and received his PhD in Organic Chemistry at Yale University under the guidance of Prof. Andrew D. Hamilton (2002).